Mother's milk, feeding strategies, and lactoferrin to prevent necrotizing enterocolitis

Journal of Parenteral and Enteral Nutrition

Volumn 36, Issue 1 SUPPL., 2012, Pages

  Adamkin, David H ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LACTOFERRIN; PLACEBO;

BREAST MILK; CONFERENCE PAPER; DRUG ACTIVITY; ENTERIC FEEDING; FEEDING; GROWTH DISORDER; HUMAN; INNATE IMMUNITY; NECROTIZING ENTEROCOLITIS; OSTEOPENIA; PREMATURITY; PRIORITY JOURNAL; TREATMENT PLANNING; VERY LOW BIRTH WEIGHT; CLINICAL TRIAL (TOPIC); FEMALE; INFANT NUTRITION; METHODOLOGY; MULTICENTER STUDY (TOPIC); NEWBORN; PATHOPHYSIOLOGY; REVIEW;

CLINICAL TRIALS AS TOPIC; ENTERAL NUTRITION; ENTEROCOLITIS, NECROTIZING; FEMALE; HUMANS; IMMUNITY, INNATE; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; LACTOFERRIN; MILK, HUMAN; MULTICENTER STUDIES AS TOPIC;

EID: 84860592128     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607111420158     Document Type: Conference Paper

References (45)

1. Obladen M. Necrotizing enterocolitis: 150 years of fruitless search for the cause. Neonatology. 2009;96:203-210.
2. Homan R, Stoll B, Curns A, Yorita K, Steiner C, Schonberger L. Necrotising enterocolitis hospitalizations among neonates in the United States. Paediatr Perinat Epidemiol. 2006;20:498-506.
3. Guillet R, Stoll B, Cotten C, et al. Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics. 2006;117:e137-e142.
4. Horbar J, Badger G, Carpenter J, et al. Trends in mortality and morbidity for very low birth weight infants, 1991-1999. Pediatrics. 2002;110:143-151.
5. Erasmus H, Ludwig-Auser H, Paterson P, Sun D, Sankaran K. Enhanced weight gain in preterm infants receiving lactase-treated feeds: a randomized, double-blind, controlled trial. J Pediatr. 2002;141:532-537.
6. Fitzgibbons S, Ching Y, Yu D, et al. Mortality of necrotizing enterocolitis expressed by birth weight catagories. J Pediatr Surg. 2009;44:1072-1075.
7. Schanler R, Shulman R, Lau C. Feeding strategies for premature infants: beneficial outcomes of feeding fortified human milk vs preterm formula. Pediatrics. 1999;103:1150-1157.
8. Arnold L. The cost-effectiveness of using banked donor milk in the neonatal intensive care unit: prevention of necrotizing enterocolitis. J Hum Lact. 2002;18:172-177.
9. Boyd C, Quigley M, Brocklehurs P. Donor breast milk versus infant formula for preterm infants: a systematic review and metaanalysis. Arch Dis Child Fetal Neonatal Ed. 2007;92:F169-F175.
10. Lucas A, Cole T. Breast milk and neonatal necrotizing enterocolitis. Lancet. 1990;336:1519-1523.
11. McGuire W, Anthony M. Donor human milk versus formula for preventing necrotizing enterocolitis in preterm infants: systematic review. Arch Dis Child Fetal Neonatal Ed. 2003;88:F11-F14.
12. Quigley M, Henderson G, Anthony M, McGuire W. Formula milk versus donor breast milk for feeding preterm or low birth weight infants (review). Cochrane Database Syst Rev. 2007;4:CD002971.
13. Lucas A, Fewtrell M, Morley R, et al. Randomized outcome trial of human milk fortification and developmental outcome in preterm infants. Am J Clin Nutr. 1996;64:142-151.
14. Sullivan S, Schanler R, Kim J, et al. An exclusively human milk based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk based products. J Pediatr. 2010;156:562-567.
15. Narayan I, Gupta J. Human milk and neonatal infections. Acta Paediatr Scand Suppl. 1989;351:126-130.
16. Koivusalo A, Kauppinen H, Anttila A, et al. Intraluminal casein model of nectrotizing enterocolitis for assessment of mucosal destruction, bacterial translocation, and the effects of allopurinol and N-acetycysteine. Pediatr Surg Int. 2002;18:712-717.
17. Brown E, Sweet A. Preventing necrotizing enterocolitis in neonates. JAMA. 1978;240:2452-2454.
18. Chuhan M, Henderson G, McGuire W. Enteral feeding for very low birth weight infants: reducing the risk of necrotizing enterocolitis. Arch Dis Child Fetal Neonatal Ed. 2008;93:F162-F166.
19. Anderson D, Kliegman R. The relationship of neonatal alimentation practices to the occurrence of endemic necrotizing enterocolitis. Am J Perinatol. 1991;8:62.
20. Rayyis S, Ambalavanan N, Wright L, et al. Randomized trial of "slow" versus "fast" feed advancements on the incidence of NEC in very low birth weight infants. J Pediatr. 1999;134:293-297.
21. Ziegler E, Thureen P, Carlson S. Aggressive nutrition of the very low birth weight infant. Clin Perinatol. 2002;29:225-244.
22. Mihatsch W, von Schoenaich P, Fahnenstich H, et al. The significance of gastric residuals in the early enteral feeding advancement of extremely low birth weight infants. Pediatrics. 2002;109:457-459.
23. Neu J, Walker K. Medical progress necrotizing enterocolitis. N Engl J Med. 2011;364:255-364.
24. Speer C. Inflammatory mechanisms in neonatal chronic lung disease. Eur J Pediatr. 1999;158:S18-S22.
25. Adams-Chapman I, Stoll B. Neonatal infection and long-term neurodevelopmental outcome in the preterm infant. Curr Opin Infect Dis. 2006;19:290-297.
26. Ward P, Paz E, Conneely O. Multifunctional roles of lactoferrin: a critical overview. Cell Mol Life Sci. 2005;62(22):2540-2548.
27. Hennart P, Brasseur D, Delogne-Desnoeck J, Dramaix M, Robyn C. Lysozyme, lactoferrin, and secretory immunoglobulin A content in breast milk: influence of duration of lactation, nutrition status, prolactin status, and parity of mother. Am J Clin Nutr. 1991;53:323-329.
28. Leitch E, Wilcox M. Elucidation of the antistaphylococcal action of lactoferrin and lysozyme. J Med Microbiol. 1999;48:867-871.
29. Kuipers M, de Vries H, Eikelboom M, Meijer D, Swart P. Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates. Antimicrob Agents Chemother. 1999;43:2635-2641.
30. Hasegawa K, Motsuchi W, Tanaka S, Dosako S. Inhibition with lactoferrin of in vitro infection with human herpes virus. Jpn J Med Sci Biol. 1994;47:73-85.
31. Kalmar J, Arnold R. Killing of Actinobacillus actinomycetemcomitans by human lactoferrin. Infect Immun. 1988;56:2552-2557.
32. Farnaud S, Evans R. Lactoferrin-a multifunctional protein with antimicrobial properties. Mol Immunol. 2003;40:395-405.
33. Suzuki Y, Lopez V, Lonnerdal B. Mammalian lactoferrin receptors: structure and function. Cell Mol Life Sci. 2005;62:2560-2575.
34. Bellamy W, Takase M, Wakabayashi H, Kawase K, Tomita M. Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J Appl Bacteriol. 1992;73:472-479.
35. Mulligan P, White N, Monteleone G, et al. Breast milk lactoferrin regulates gene expression by binding bacterial DNA CpG motifs but not genomic DNA promoters in model intestinal cells. Pediatr Res. 2006;59:656-661.
36. Sherman M. New concepts of microbial translocation in the neonatal intestine: mechanisms and prevention. Clin Perinatol. 2010;37:565-579.
37. Manzoni P, Rinaldi M, Cattani S, et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low birth weight neonates: a randomized trial. JAMA. 2009;302: 1421-1428.
38. Yamauchi K, Wakabayashi H, Shin K, Takase M. Bovine lactoferrin: benefits and mechanism of action against infections. Biochem Cell Biol. 2006;84:291-296.
39. Kaufman D. Editorial: lactoferrin supplementation to prevent nosocomial infections in preterm infants. JAMA. 2009;302:1421-1428.
40. Meinzen-Derr J, Poindexter B, Wrage L, Morrow A, Stoll B, Donovan E. Role of human milk in extremely low birth weight infants' risk of necrotizing enterocolitis or death. J Perinatol. 2009;29:57-62.
41. Sisk P, Lovelady C, Dillard R, Gruber J, O'Shea T. Early human milk feeding is associated with a lower risk of necrotizing enterocolitis in very low birth weight infants. J Perinatol. 2007;27:428-433.
42. Fanaroff A, Stoll B, Wright L, et al. Trends in neonatal morbidity and mortality for very low birth weight infants. Am J Obstet Gynecol. 2007;196:147, e1-e8.
43. Berlutti F, Schippa S, Morea C, et al. Lactoferrin downregulates pro-inflammatory cytokines upexpressed in intestinal epithelial cells infected with invasive or noninvasive Escherichia coli strains. Biochem Cell Biol. 2006;84:351-357.
44. Otsuki K, Yakuwa K, Sawada M, et al. Recombinant human lactoferrin has preventive effects on lipopolysaccharide-induced preterm delivery and production of inflammatory cytokines in mice. J Perinal Med. 2005;33:320-323.
45. Buccigrossi V, de Marco G, Bruzzese E, et al. Lactoferrin induces concentration-dependent functional modulation of intestinal proliferation and differentiation. Pediatr Res. 2007;61:410-414.